THE DEAL, AT A GLANCE
From the announcementMirador Therapeutics
01Who is involvedBacked by Atlas Venture, Foresite CapitalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedMirador Therapeutics raised $250M Series BFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersMirador Therapeutics' $250M Series B positions the company as an upper-tier Healthcare & Life Sciences financing in a sector with heavy recent capital formation.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Mirador Therapeutics · Financing Record
Explore source-linked visual explanations for Mirador Therapeutics. Unsupported claims are withheld while source review continues.
Record 138 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →